Showing all 8 results
Telmisartan 40Mg + Amlodipine 5Mg + Hydroclorthiazide 12.5Mg Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Multi-Layer or Segregated Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic ARB and the sensitive CCB.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Continuous 24-hour peripheral vasodilation and potassium-sparing RAAS blockade. Amlodipine Besylate USP/Ph.Eur. 5 mg (Equivalent to Amlodipine base) Calcium channel blockade for direct arterial relaxation and anti-anginal defense. Hydrochlorothiazide (HCTZ) USP/Ph.Eur. 12.5 mg Thiazide diuresis for blood volume reduction and mitigation of peripheral edema. Excipients Meglumine / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate Alkalizer for Telmisartan / Diluent / Superdisintegrant (Engineered for kinetic segregation) *Pack Sizes: 10×10 or 10×15 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology adherence regimens).
Telmisartan 40Mg + Chlorthalidone 6.25Mg Tablet
FreeA Telmisartan 40mg + Chlorthalidone 6.25mg tablet is a fixed-dose combination antihypertensive medication used to treat high blood pressure (hypertension) when a single medicine is not effective enough.
Telmisartan 40mg and Metoprolol 25mg Tablets
FreeA Telmisartan 40mg + Metoprolol 25mg tablet is a combination antihypertensive medication used to manage high blood pressure (hypertension).
Telmisartan 50Mg + Metoprolol Succinate Entric Coated 40Mg Tablets
FreeA Telmisartan 40mg + Metoprolol Succinate 50mg (often referred to as enteric-coated or extended-release) tablet is a fixed-dose combination antihypertensive medication. It is primarily used to treat hypertension (high blood pressure) when a single medicine is insufficient, as well as to reduce the risk of heart attack and stroke.
Ticagrelor Tablets
FreeTicagrelor tablets primarily contain Ticagrelor as the active pharmaceutical ingredient. It is a direct-acting P2Y12 receptor antagonist used as an antiplatelet medication to prevent blood clots in patients with a history of heart attack or acute coronary syndrome (ACS)
